MAPT and Alzheimer disease: Altogether, it is likely that the commonly used AD biomarkers (increased GSK-3β activity, tau protein hyperphosphorylation and Aβ accumulation) are associated with memory impairment in patients with diabetes, suggesting the potential application of these biomarkers in DM patients.